Navigation Links
Voices Against Brain Cancer Discusses Possible Breakthrough in Brain Cancer Treatment
Date:9/19/2013

New York, NY (PRWEB) September 19, 2013

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a possible breakthrough in brain cancer treatment that could potentially double survival rates, according to Dr. Charles Cobbs of California Pacific Medical Center.

According to a September 13, 2013 article published by Komo News titled “Doctor brings breakthrough brain cancer treatment to Seattle,” Dr. Charles Cobbs, a surgeon and oncologist at California Pacific Medical Center, has spent several years experimenting with a new brain cancer treatment that could potentially double survival rates.

Because of limited research, potential side effects and high costs, his approach has not been “embraced by the entire medical community.” However, Cobbs is hoping his new job as director of the Ivy Center for Advanced Brain Tumor Treatment in Seattle will provide him with the opportunity to lead further research into saving those who suffer from the terrible disease.

The article states that, over the past several years, Cobbs has focused his research on Cytomegalovirus, a common virus that infects “50 to 80 percent of adults by age 40.” He tested cancerous tumor samples and found that every single one tested positive for cytomegalovirus.

With this newfound discovery, he shifted his focus to the antiviral drug valganciclovir (Valcyte) which is typically used to treat the virus in AIDS patients. Cobbs, in collaboration with Dr. Cecilia Soderberg-Naucler, started a clinical trial treating glioblastoma patients with Valcyte in addition to the standard brain cancer treatment protocol of surgery, chemotherapy and radiation.

The median survival rate for glioblastoma is normally 15 months and only about 15 to 20 percent of patients live for two years or more. However, 90 percent of trial patients on Valcyte lived for at least two years after their primary diagnosis. The median survival rate for patients in the clinical trial was 56 months, approximately over four and a half years.

“If these results are able to be repeated it would be the biggest breakthrough ever by far for brain cancer treatment,” says Cobb. “Successes in the past decade have only increased median survival rates by a couple months. We’re talking about doubling survival rates.”

Michael Klipper, chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, says breakthrough news like this is extremely comforting to those in the brain cancer community. “Brain cancer has probably one of the grimmest prognoses of all cancers. The news of this possible new treatment provides those who have been directly affected with brain cancer with the hope that there will one day be a cure.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.

#####

Read the full story at http://www.prweb.com/releases/2013/9/prweb11133346.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Version 2.0 of Award-Winning Proloquo2Go App for iPhone, iPad & iPod touch Speeds Up Communication, Adds New Voices and Customization Options
2. Kentucky Social Security Disability Benefits Lawyer with The Frank Jenkins Law Office Voices Support for Recent Expansion of Compassionate Allowance Program
3. Voices Against Brain Cancer Responds to a Mother’s Successful Fight Against her Glioblastoma
4. Voices Against Brain Cancer Commends a Surgical Innovation That Lights Up Brain Tumors
5. Yakima Traumatic Injury Lawyer Mariano Morales Voices Support for Brain Injury Awareness Month
6. Voices Against Brain Cancer Comments on Link Between Cell Phone Use and Brain Cancer
7. Factoring Receivables & Factoring Invoices Experts Universal Funding Announces Move
8. Voices Against Brain Cancer Commends Andrew Bauer For Raising Awareness About Brain Cancer
9. Voices Against Brain Cancer Responds to Research Identifying Contributing Factor in Brain Tumors
10. Voices Against Brain Cancer Offers Support to Songwriter Battling Brain Cancer
11. Voices Against Brain Cancer Commends Brain Cancer Patient Iram Leon for Winning a Marathon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... ... charity program created to assist the people of their local community. The agency ... organizations and community leaders. Their hope is to bring awareness to important local ...
(Date:5/4/2016)... ... ... Dr. Elyson and Dr. Assili, dentist in Northridge , announce that they ... common dental procedure, is performed for many adolescents and young adults today. While wisdom ... complications. By providing wisdom tooth removal surgery at their office, Dr. Elyson and Dr. ...
(Date:5/4/2016)... ... ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car rental business ... at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses and driving ... her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 in both ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco ... compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . ... retail starting at $59.95) uses 2 included CR-123 batteries to produce up to ...
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , There ... UTIs, have plagued people since the beginning of recorded medical history, and in ... every year. It's not just a matter of inconvenience; bladder infections cost us billions ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 Valeritas Holdings, ... an alternative public offering (APO). This was accomplished via ... Valeritas, Inc. and a private placement of approximately 5 ... per share. Under the terms of the ... Valeritas Holdings, Inc. will trade on the OTC Markets ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: